down arrow

IQVIA Holdings, Inc.

  • Market Cap: Mid Cap
  • Industry: Miscellaneous
  • ISIN: US46266C1053
USD
224.92
-2.32 (-1.02%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

214.01225.74

52 Week

134.65234.06
Valuation
Technical
Day's Volume

CASH

525.28 k

Shareholding (Mar 2025)

FII

27.04%

Held by 463 FIIs

DII

38.26%

Held by 54 DIIs

Promoter

0.24%

How big is IQVIA Holdings, Inc.?

22-Jun-2025

As of Jun 18, IQVIA Holdings, Inc. has a market capitalization of $39.31 billion, with net sales of $15.50 billion and a net profit of $1.33 billion for the latest four quarters.

As of Jun 18, IQVIA Holdings, Inc. has a market capitalization of 39,310.91 million, classifying it as a Large Cap company.<BR><BR>As of Jun 18, the company reported net sales of 15,496.00 million and a net profit of 1,334.00 million for the latest four quarters.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 6,067.00 million and total assets of 26,899.00 million.

Read More

What does IQVIA Holdings, Inc. do?

22-Jun-2025

IQVIA Holdings, Inc. provides integrated information and technology-enabled healthcare services, with a market capitalization of approximately $39.31 billion. As of March 2025, it reported net sales of $3.83 billion and a net profit of $249 million.

Overview:<BR>IQVIA Holdings, Inc. provides integrated information and technology-enabled healthcare services and operates in the Miscellaneous industry with a large-cap market capitalization.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 3,831 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 249 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 39,310.91 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 29.00 <BR>Debt Equity: 2.08 <BR>Return on Equity: 22.52% <BR>Price to Book: 6.58<BR><BR>Contact Details:<BR>Address: 4820 Emperor Blvd, DURHAM NC: 27703-8426 <BR>Tel: 1 919 9982000 <BR>Website: https://ir.iqvia.com/

Read More

Who are in the management team of IQVIA Holdings, Inc.?

22-Jun-2025

As of March 2022, the management team of IQVIA Holdings, Inc. is led by Mr. Ari Bousbib as Chairman, President, and CEO, with Dr. John Leonard serving as Lead Independent Director and a board that includes independent directors Ms. Carol Burt, Mr. John Connaughton, Mr. John Danhakl, and Mr. James Fasano.

As of March 2022, the management team of IQVIA Holdings, Inc. includes Mr. Ari Bousbib, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the board features Dr. John Leonard as the Lead Independent Director, along with independent directors Ms. Carol Burt, Mr. John Connaughton, Mr. John Danhakl, and Mr. James Fasano.

Read More

Is IQVIA Holdings, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, IQVIA Holdings, Inc. shows a bullish trend supported by strong moving averages and MACD indicators, despite a bearish weekly RSI and mixed signals from KST, while outperforming the S&P 500 in the short term but underperforming over the past year.

As of 3 October 2025, the technical trend for IQVIA Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, supporting the overall positive stance. However, the weekly RSI is bearish, indicating some short-term weakness. The Bollinger Bands show a mildly bullish trend on the weekly and bullish on the monthly. The KST is bullish weekly but bearish monthly, and Dow Theory indicates no trend weekly and mildly bullish monthly. <BR><BR>In terms of performance, IQVIA has outperformed the S&P 500 over the past week and month, with returns of 13.45% and 9.24% compared to 1.09% and 4.15% for the index, respectively. However, it has underperformed over the longer term, with a 1-year return of -10.80% versus 17.82% for the S&P 500. Overall, the current stance is bullish, driven by strong moving averages and MACD indicators, despite some mixed signals from RSI and KST.

Read More

Is IQVIA Holdings, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, IQVIA Holdings, Inc. is considered overvalued with a P/E ratio of 29, higher than its peers, and has underperformed the S&P 500 over the past one and three years.

As of 17 October 2025, the valuation grade for IQVIA Holdings, Inc. moved from very expensive to expensive. Based on the current metrics, the company appears to be overvalued. The P/E ratio stands at 29, which is significantly higher than the peer average of 29.20 for Laboratory Corp. of America Holdings and 27.82 for Quest Diagnostics, Inc. Additionally, the EV to EBITDA ratio of 15.15 is also above the peer average of 14.94 for Laboratory Corp. of America, indicating a premium valuation compared to its peers.<BR><BR>In terms of returns, IQVIA has underperformed against the S&P 500 over the one-year and three-year periods, with returns of -12.54% and 12.90%, respectively, compared to the S&P 500's 14.08% and 81.19%. This underperformance further supports the conclusion that IQVIA Holdings, Inc. is currently overvalued in the market.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • INTEREST COVERAGE RATIO(Q) Lowest at 443.72
  • RAW MATERIAL COST(Y) Grown by 6.29% (YoY)
  • DEBT-EQUITY RATIO (HY) Highest at 233.85 %
2

With ROCE of 12.33%, it has a expensive valuation with a 2.78 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 47,314 Million (Mid Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.30

stock-summary
Return on Equity

22.50%

stock-summary
Price to Book

8.19

Revenue and Profits:
Net Sales:
4,015 Million
(Quarterly Results - Jun 2025)
Net Profit:
266 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.19%
0%
22.19%
6 Months
52.08%
0%
52.08%
1 Year
10.71%
0%
10.71%
2 Years
4.0%
0%
4.0%
3 Years
3.3%
0%
3.3%
4 Years
-14.05%
0%
-14.05%
5 Years
31.83%
0%
31.83%

IQVIA Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
IQVIA Holdings Faces Financial Strain Amid Declining Metrics and Increased Costs

IQVIA Holdings Faces Financial Strain Amid Declining Metrics and Increased Costs

IQVIA Holdings, Inc. has recently experienced a change in its evaluation, reflecting a shift in financial metrics following a challenging quarter in June 2025. Key indicators show a decline in the interest coverage ratio and an increase in raw material costs, alongside rising leverage concerns and underperformance relative to the S&P 500.

Read More

Is IQVIA Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for IQVIA Holdings, Inc. moved from very expensive to expensive. Based on the current metrics, the company appears to be overvalued. The P/E ratio stands at 29, which is significantly higher than the peer average of 29.20 for Laboratory Corp. of America Holdings and 27.82 for Quest Diagnostics, Inc. Additionally, the EV to EBITDA ratio of 15.15 is also above the peer average of 14.94 for Laboratory Corp. of America, indicating a premium valuation compared to its peers. In terms of returns, IQVIA has underperformed against the S&P 500 over the one-year and three-year periods, with returns of -12.54% and 12.90%, respectively, compared to the S&P 500's 14.08% and 81.19%. This underperformance further supports the conclusion that IQVIA Holdings, Inc. is currently overvalued in the market....

Read More
IQVIA Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

IQVIA Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

IQVIA Holdings, Inc. has adjusted its valuation, showcasing a P/E ratio of 29 and a price-to-book value of 6.50. The company has demonstrated resilience with a recent 1-week return of 3.22%, although its long-term performance has lagged behind the S&P 500.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.47%
EBIT Growth (5y)
25.95%
EBIT to Interest (avg)
3.35
Debt to EBITDA (avg)
3.96
Net Debt to Equity (avg)
2.08
Sales to Capital Employed (avg)
0.76
Tax Ratio
18.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.37%
ROCE (avg)
9.82%
ROE (avg)
17.67%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
6.50
EV to EBIT
22.58
EV to EBITDA
15.15
EV to Capital Employed
2.78
EV to Sales
3.31
PEG Ratio
28.87
Dividend Yield
NA
ROCE (Latest)
12.33%
ROE (Latest)
22.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 168 Schemes (34.46%)

Foreign Institutions

Held by 463 Foreign Institutions (27.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 5.27% vs 2.53% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -26.72% vs 22.22% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,015.00",
          "val2": "3,814.00",
          "chgp": "5.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "812.00",
          "val2": "817.00",
          "chgp": "-0.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "183.00",
          "val2": "178.00",
          "chgp": "2.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-30.00",
          "val2": "32.00",
          "chgp": "-193.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "266.00",
          "val2": "363.00",
          "chgp": "-26.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.50%",
          "val2": "143.70%",
          "chgp": "-1.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.95% vs 3.77% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.10% vs 24.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15,405.00",
          "val2": "14,963.00",
          "chgp": "2.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,383.00",
          "val2": "3,165.00",
          "chgp": "6.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "711.00",
          "val2": "719.00",
          "chgp": "-1.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.00",
          "val2": "-32.00",
          "chgp": "112.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,373.00",
          "val2": "1,358.00",
          "chgp": "1.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "147.30%",
          "val2": "136.30%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
4,015.00
3,814.00
5.27%
Operating Profit (PBDIT) excl Other Income
812.00
817.00
-0.61%
Interest
183.00
178.00
2.81%
Exceptional Items
-30.00
32.00
-193.75%
Consolidate Net Profit
266.00
363.00
-26.72%
Operating Profit Margin (Excl OI)
133.50%
143.70%
-1.02%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 5.27% vs 2.53% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -26.72% vs 22.22% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
15,405.00
14,963.00
2.95%
Operating Profit (PBDIT) excl Other Income
3,383.00
3,165.00
6.89%
Interest
711.00
719.00
-1.11%
Exceptional Items
4.00
-32.00
112.50%
Consolidate Net Profit
1,373.00
1,358.00
1.10%
Operating Profit Margin (Excl OI)
147.30%
136.30%
1.10%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.95% vs 3.77% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.10% vs 24.47% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About IQVIA Holdings, Inc. stock-summary
stock-summary
IQVIA Holdings, Inc.
Miscellaneous
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
Company Coordinates stock-summary
Company Details
4820 Emperor Blvd , DURHAM NC : 27703-8426
stock-summary
Tel: 1 919 9982000
stock-summary
https://ir.iqvia.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."